In a significant/important/landmark development for the treatment of spinal muscular atrophy (SMA), the Delhi High Court has upheld/approved/supported the regulatory approval/permission/sanction for the drug risdiplam https://louiseibrp946771.blogdigy.com/hc-confirms-official-approval-for-risdiplam-in-india-58482881